Treatment of Hypophysitis in Male Patients with Central Hypogonadism

In male patients, Hypophysitis can disrupt pituitary function and result in central hypogonadism. This scenario calls for specific hormonal management alongside the primary diagnosis.

Central hypogonadism in this setting requires targeted intervention. Testosterone replacement is necessary to address its consequences, which include effects on bone mineral density, libido, sexual function, muscle mass, strength, and risk of anaemia.

Treatment Approach

Management centres on testosterone replacement therapy. The specific formulation is not fixed — selection is guided by individual patient preference, regional availability, and cost.

The complete clinical algorithm, full list of formulation options, and decision criteria are in the full protocol →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.beem.2019.101371

Testosterone replacement is necessary for male patients with central hypogonadism in order to improve bone mineral density, libido, sexual function, maintenance of muscle mass, strength, and prevention of anaemia.

Several testosterone formulations are available and choice of the formulation depends on the patient's preference, regional availability, and cost.

View source ↗